Qiagen NV (QGEN)
43.62
+0.04
(+0.09%)
USD |
NYSE |
May 10, 16:00
43.62
0.00 (0.00%)
After-Hours: 17:18
Qiagen Free Cash Flow (Quarterly): 94.72M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 94.72M |
| December 31, 2023 | 99.15M |
| September 30, 2023 | 83.64M |
| June 30, 2023 | 80.35M |
| March 31, 2023 | 33.52M |
| December 31, 2022 | 77.73M |
| September 30, 2022 | 184.86M |
| June 30, 2022 | 134.34M |
| March 31, 2022 | 169.00M |
| December 31, 2021 | 144.46M |
| September 30, 2021 | 104.24M |
| June 30, 2021 | 110.10M |
| March 31, 2021 | 73.67M |
| December 31, 2020 | 203.07M |
| September 30, 2020 | -50.22M |
| June 30, 2020 | 12.73M |
| March 31, 2020 | -12.01M |
| December 31, 2019 | 59.14M |
| September 30, 2019 | 58.39M |
| June 30, 2019 | 46.48M |
| March 31, 2019 | -108.05M |
| December 31, 2018 | 62.80M |
| September 30, 2018 | 46.11M |
| June 30, 2018 | 85.71M |
| March 31, 2018 | 14.12M |
| Date | Value |
|---|---|
| December 31, 2017 | 43.16M |
| September 30, 2017 | 45.72M |
| June 30, 2017 | 37.74M |
| March 31, 2017 | 35.75M |
| December 31, 2016 | 73.64M |
| September 30, 2016 | 73.28M |
| June 30, 2016 | 73.12M |
| March 31, 2016 | 27.64M |
| December 31, 2015 | 51.40M |
| September 30, 2015 | 70.75M |
| June 30, 2015 | 40.02M |
| March 31, 2015 | 37.85M |
| December 31, 2014 | 49.48M |
| September 30, 2014 | 69.92M |
| June 30, 2014 | 45.19M |
| March 31, 2014 | 26.38M |
| December 31, 2013 | 41.39M |
| September 30, 2013 | 54.40M |
| June 30, 2013 | 21.30M |
| March 31, 2013 | 23.18M |
| December 31, 2012 | 27.32M |
| September 30, 2012 | 36.40M |
| June 30, 2012 | 65.18M |
| March 31, 2012 | -12.10M |
| December 31, 2011 | 30.66M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-50.22M
Minimum
Sep 2020
203.07M
Maximum
Dec 2020
85.37M
Average
82.00M
Median
Free Cash Flow (Quarterly) Benchmarks
| MoonLake Immunotherapeutics | -15.16M |
| LENZ Therapeutics Inc | -- |
| Thermo Fisher Scientific Inc | 904.00M |
| uniQure NV | -51.58M |
| ProQR Therapeutics NV | -6.575M |